Wednesday 17 April 2024

Episode 13: Professor Amit Nathwani’s journey to create a one-shot haemophilia A cure

  • Open to all
  • Podcast
Listen on SoundCloudListen on Spotify
Graphic with two headshot photos

To mark World Haemophilia Day, we sit down with Professor Amit Nathwani of the UCL Cancer Institute to explore his journey to commercialising the groundbreaking haemophilia A treatment, Roctavian.

Amit’s lab to market story, working with UCLB, led to the creation of Roctavian, a one-time gene therapy used for the treatment of adults with severe haemophilia A. The therapy, which was licensed to Biomarin Pharmaceutical Inc, received marketing approval in Europe in 2022 and US FDA approval in 2023 and is now available to patients commercially.

Host Nigel Campbell is joined by Amit and UCLB Director of Biopharm Rick Fagan to explore how Amit’s work for the NHS looking after patients with haemophilia instilled a mission to develop a 'one and done' vaccine type approach to the condition.

Soundtrack by Harry Penfold and Thomas Shearwood.

Release date: 17 April 2024

Further Information:

Click here to read the full transcript.

Browse UCL Minds podcasts here.

All podcasts